Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combined analysis of RNA-sequence and microarray data reveals effective metabolism-based prognostic signature for neuroblastoma.

Journal of cellular and molecular medicine - 1 Sept 2020

Meng Xinyao, Feng Chenzhao, Fang Erhu, Feng Jiexiong, Zhao Xiang

Abstract excerpt

The relationship between metabolism reprogramming and neuroblastoma (NB) is largely unknown. In this study, one RNA-sequence data set (n = 153) was used as discovery cohort and two microarray data sets (n = 498 and n = 223) were used as validation cohorts. Differentially expressed metabolic genes were identified by comparing stage 4s and stage 4 NBs. Twelve metabolic genes were selected by LASSO regression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to Kaplan-Meier Estimate

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Microarray Analysis

Share to Molecular Sequence Annotation

Share to Neuroblastoma

Share to Reproducibility of Results

Share to RNA, Long Noncoding

Share to RNA-Seq

Source

Open in PubMed Open full text

Identifiers

PMID: 32683778
DOI: 10.1111/jcmm.15650
PMCID: PMC7521294

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combined analysis of RNA-sequence and microarray data reveals effective metabolism-based prognostic signature for neuroblastoma.PMID 32683778Read ↗

Metabolism and Tumor Microenvironment-Associated Molecular Classification of NeuroblastomaSemantic proximity Read ↗

A prognostic metabolism-related gene signature associated with the tumor immune microenvironment in neuroblastomaSemantic proximity Read ↗

Joint analysis of the metabolomics and transcriptomics uncovers the dysregulated network and develops the diagnostic model of high-risk neuroblastomaSemantic proximity Read ↗

Integrated single-cell and transcriptomic analysis of bone marrow-derived metastatic neuroblastoma reveals molecular mechanisms of metabolic reprogrammingSemantic proximity Read ↗

Identification and Validation of a Novel Metabolism‑Related Prognostic Signature in Hepatocellular CarcinomaSemantic proximity Read ↗

Construction and Validation of a Metabolic Reprogramming Related Prognostic Model for Hepatocellular CarcinomaSemantic proximity Read ↗

Identification and Characterization of a Glucometabolic Prognostic Gene Signature in Neuroblastoma based on N6-methyladenosine Eraser ALKBH5Semantic proximity Read ↗

Prognostic Exploration of Metabolism-Related Genes in Hepatocellular Carcinoma and Pan-CancerSemantic proximity Read ↗

A Comprehensive Metabolism-Related Gene Signature Predicts the Survival of Patients with Acute Myeloid LeukemiaSemantic proximity Read ↗

Development and validation of a CTNNB1-associated metabolic prognostic model for hepatocellular carcinoma.Semantic proximity Read ↗

Identification of a novel metabolism‑related prognostic signature in hepatocellular carcinoma through bioinformatics analysis and validation through experimental studiesSemantic proximity Read ↗

Identification of a prognostic metabolic gene signature in diffuse large B‐cell lymphomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.